IT1145403B - Derivati di 1,2-diidro-2-osso-4-fenil-3-chinolin-carbonitrile dotati di proprieta' anti-infiammatorie - Google Patents

Derivati di 1,2-diidro-2-osso-4-fenil-3-chinolin-carbonitrile dotati di proprieta' anti-infiammatorie

Info

Publication number
IT1145403B
IT1145403B IT8047580A IT4758080A IT1145403B IT 1145403 B IT1145403 B IT 1145403B IT 8047580 A IT8047580 A IT 8047580A IT 4758080 A IT4758080 A IT 4758080A IT 1145403 B IT1145403 B IT 1145403B
Authority
IT
Italy
Prior art keywords
fenyl
quinolin
dihydro
bone
inflammatory properties
Prior art date
Application number
IT8047580A
Other languages
English (en)
Other versions
IT8047580A0 (it
Inventor
Chester P Turk
John Krapcho
Original Assignee
Squibb & Sons Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Squibb & Sons Inc filed Critical Squibb & Sons Inc
Publication of IT8047580A0 publication Critical patent/IT8047580A0/it
Application granted granted Critical
Publication of IT1145403B publication Critical patent/IT1145403B/it

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D215/54Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D281/00Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one sulfur atom as the only ring hetero atoms
    • C07D281/02Seven-membered rings
    • C07D281/04Seven-membered rings having the hetero atoms in positions 1 and 4
    • C07D281/08Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
    • C07D281/10Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems condensed with one six-membered ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Quinoline Compounds (AREA)
IT8047580A 1979-01-29 1980-01-11 Derivati di 1,2-diidro-2-osso-4-fenil-3-chinolin-carbonitrile dotati di proprieta' anti-infiammatorie IT1145403B (it)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/007,069 US4232027A (en) 1979-01-29 1979-01-29 1,2-Dihydro-2-oxo-4-phenyl-3-quinolinecarbonitrile derivatives

Publications (2)

Publication Number Publication Date
IT8047580A0 IT8047580A0 (it) 1980-01-11
IT1145403B true IT1145403B (it) 1986-11-05

Family

ID=21724050

Family Applications (1)

Application Number Title Priority Date Filing Date
IT8047580A IT1145403B (it) 1979-01-29 1980-01-11 Derivati di 1,2-diidro-2-osso-4-fenil-3-chinolin-carbonitrile dotati di proprieta' anti-infiammatorie

Country Status (6)

Country Link
US (1) US4232027A (it)
JP (1) JPS55102568A (it)
DE (1) DE3003146A1 (it)
FR (1) FR2447376A1 (it)
GB (1) GB2041361B (it)
IT (1) IT1145403B (it)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0024638A1 (en) * 1979-08-30 1981-03-11 Byk Gulden Lomberg Chemische Fabrik GmbH Substituted quinolinone-alkanecarboxylic acids, their preparation, and medicaments containing them
JPH03181465A (ja) * 1989-12-11 1991-08-07 Takeda Chem Ind Ltd キノリン誘導体
TW384285B (en) * 1994-03-08 2000-03-11 Takeda Chemical Industries Ltd Pharmaceutical composition containing quinoline or quinazoline derivatives and novel derivatives therefor
EP1667973B1 (en) * 2003-09-23 2013-12-04 Merck Sharp & Dohme Corp. Quinoline potassium channel inhibitors
UA124474C2 (uk) 2016-12-22 2021-09-22 Емджен Інк. БЕНЗІЗОТІАЗОЛЬНІ, ІЗОТІАЗОЛО[3,4-b]ПІРИДИНОВІ, ХІНАЗОЛІНОВІ, ФТАЛАЗИНОВІ, ПІРИДО[2,3-d]ПІРИДАЗИНОВІ Й ПІРИДО[2,3-d]ПІРИМІДИНОВІ ПОХІДНІ ЯК ІНГІБІТОРИ G12C KRAS ДЛЯ ЛІКУВАННЯ РАКУ ЛЕГЕНІ, РАКУ ПІДШЛУНКОВОЇ ЗАЛОЗИ АБО КОЛОРЕКТАЛЬНОГО РАКУ
JOP20190272A1 (ar) 2017-05-22 2019-11-21 Amgen Inc مثبطات kras g12c وطرق لاستخدامها
AU2018329920B2 (en) 2017-09-08 2022-12-01 Amgen Inc. Inhibitors of KRAS G12C and methods of using the same
MA52496A (fr) 2018-05-04 2021-03-10 Amgen Inc Inhibiteurs de kras g12c et leurs procédés d'utilisation
JP7266043B2 (ja) 2018-05-04 2023-04-27 アムジエン・インコーポレーテツド KRas G12C阻害剤及びそれを使用する方法
AU2019265822A1 (en) 2018-05-10 2020-11-19 Amgen Inc. KRAS G12C inhibitors for the treatment of cancer
EP3802535B1 (en) 2018-06-01 2022-12-14 Amgen, Inc Kras g12c inhibitors and methods of using the same
EP4268898A3 (en) * 2018-06-11 2024-01-17 Amgen Inc. Kras g12c inhibitors for treating cancer
MX2020012261A (es) 2018-06-12 2021-03-31 Amgen Inc Inhibidores de kras g12c que comprenden un anillo de piperazina y uso de estos en el tratamiento del cancer.
JP2020090482A (ja) 2018-11-16 2020-06-11 アムジエン・インコーポレーテツド Kras g12c阻害剤化合物の重要な中間体の改良合成法
EP3883565A1 (en) 2018-11-19 2021-09-29 Amgen Inc. Kras g12c inhibitors and methods of using the same
JP7377679B2 (ja) 2018-11-19 2023-11-10 アムジエン・インコーポレーテツド がん治療のためのkrasg12c阻害剤及び1種以上の薬学的に活性な追加の薬剤を含む併用療法
EP3738593A1 (en) 2019-05-14 2020-11-18 Amgen, Inc Dosing of kras inhibitor for treatment of cancers
KR20220011670A (ko) 2019-05-21 2022-01-28 암젠 인크 고체 상태 형태
WO2024102784A1 (en) * 2022-11-09 2024-05-16 Accutar Biotechnology, Inc. Substituted quinolinone-8-carbonitrile derivatives having androgen degradation activity and uses thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3210358A (en) * 1961-08-09 1965-10-05 Geigy Chem Corp Substituted 4-amino carbostyrils
CH471784A (de) * 1966-01-26 1969-04-30 Bayer Ag Verfahren zur Herstellung von Carbostyrilderivaten
US3763153A (en) * 1972-02-22 1973-10-02 Squibb & Sons Inc Benzothiazines
US3895006A (en) * 1974-04-19 1975-07-15 Squibb & Sons Inc 5-(Substituted amino)alkyl)-2-aryl-3-halo-1,5-benzothiazepin-4(5H)-ones
US3994900A (en) * 1976-01-23 1976-11-30 E. R. Squibb & Sons, Inc. 6-(Or 8)-[[(substituted amino)alkyl]oxy(or thio)]-3,4-dihydro-4-phenyl-2(1H)-quinolinones

Also Published As

Publication number Publication date
DE3003146A1 (de) 1980-08-07
GB2041361A (en) 1980-09-10
US4232027A (en) 1980-11-04
IT8047580A0 (it) 1980-01-11
JPS55102568A (en) 1980-08-05
FR2447376A1 (fr) 1980-08-22
GB2041361B (en) 1982-12-08

Similar Documents

Publication Publication Date Title
IT1116820B (it) Derivati di moranolina con proprieta'farmacologiche
DK343980A (da) 2,4,6-triiod-isophthalsyrederivater
DK343880A (da) 2,4,6-triiod-isophthalsyrederivater
IT1145403B (it) Derivati di 1,2-diidro-2-osso-4-fenil-3-chinolin-carbonitrile dotati di proprieta' anti-infiammatorie
IT8024738A0 (it) Derivati di deformiltilosina e loro preparazione.
IT1101439B (it) Derivati di 1,3,4,5-tetraidrobenz-indolo e relativo procedimento per fabbricarli
NL191789C (nl) Acetylaminoalkaansulfonzuurderivaten met farmacologische eigenschappen.
FI802506A (fi) Anti-inflammatoriska 5-substituerade 2,3-diaryltiofener
IT1140976B (it) Derivati di alchil-chetoesopiranosidi
IT8047529A0 (it) Derivati di acido epossisuccinico dotati di proprieta' farmacologiche
MC1357A1 (fr) Derives de 2,3-indoledione
SE7708642L (sv) 1,5-disubstituerade pyrrolidoner och forfaranden for framstellning derav
IT1114721B (it) Derivati di 3,3-dicloro-2-azetidinone ad attivita' anti-infiammatoria
FI802693A (fi) Antiinflammatoriska 4,5-diaryl-alfa-polyfluoroalkyl-1h-pyrrol-2-metanoler och 1-(4,5-diaryl-1h-pyrrol-2-yl)-polyfluoroalkanoner
IT8024150A0 (it) Derivati di alovincamone eprocedimento per la loro preparazione.
IT1164906B (it) Derivati indolici dotati di proprieta' farmacologiche
IT1102751B (it) Derivati di 2,3-i-cian-pirazina
IT1158700B (it) Nuovi derivati 1h-1,2,4-triazolici 3,5-disostituiti
IT7950202A0 (it) Derivati alfa-aril-alfa alfa-bisomega-ammino bisostituiti alchilacetammidici ditati di proprieta'farmacologiche antiaritmia
IT1085538B (it) Derivati di i 125 immidazol-steroidi
IT1164729B (it) Derivati carbamoil-piperazinici dotati di attivita' farmaccologica
IT1196401B (it) Derivati acil-1h-1,2,4-triazolici
IT8020503A0 (it) Derivati della 1,1'-bifenil-2-ilalchilammina ad azione farmaceutica.
IT7825879A0 (it) D-omo ossasteroidi aventi proprieta' antinfiammatorie.
IT1113391B (it) Derivati fenilcicloesanici ad attivita' antidepressiva